Skip to main content


The study of FDI inflow in Indian Pharmaceutical Industry

Issue Abstract

Abstract
Globalization is one of the most significant happening of our time which plays an important role in the political, economic, environmental, cultural, scientific and technological aspects of a nation. Foreign Direct Investment has a vital role in globalization. FDI had contributed in India’s financial stability and economic growth. Indian economy got a gigantic boost due to the FDI made in different sectors. Indian pharmaceutical industry is considered to have a place of its own due to its capacity to deliver good quality and quantity of generic drugs and medical related products. The purpose of this research is to study FDI inflows in the Indian Pharma sector after the new economic reform. The results show that there has been a tremendous increase in FDI inflow in India since 1991.
Keywords: Globalization; FDI; Pharmaceutical.


Author Information
Dhanya .A
Issue No
11
Volume No
3
Issue Publish Date
05 Nov 2017
Issue Pages
281-286

Issue References

References
1. Balasubramanyan V.N., D.Sapsford (2007), “Does India Need A Lot More FDI?” Economic and Political
Weekly, April 28.
2. B. C. Nirmal (2007), “Indian Pharmaceutical Industry and the New Patent Regime”, The Pharma Review, April.
3. INDIA-OPPORTUNITIES, A guide to do business in India. available at http://www.indiaopportunities.es/phar maceuticalindustry.php?lang=ing website maintained Commercial Wing Embassy of India Madrid.
4. Kurien, K. Mathew (1966), “Impact of Foreign Capital on Indian Economy”, PPH, New Dei.
5. Jayashree Bose (2007), “FDI Inflows in India and China – A Sectoral Experiences”, ICFAI University Press, Hyderabad.
6. Nine Major Challenges Constraining Indian Pharmaceutical Industry from Taking a Quantum Leap pharmanewsprwire, October 1, 2012
7. M Janodia, S Pandey, J Venkara Rao, D Sreedhar, V Ligade, N Udupa (2007), Patents Regime in India: Issues, challenges and opportunities in Pharmaceutical Sector. The Internet Journal of Third World Medicine. Volume 7 Number 1.
8. M. Mazumdar (2013), Performance of Pharmaceutical Companies in India, Contributions to Economics, DOI
10.1007/978-3-7908-2876-4_2, Springer- Verlag Berlin Heidelberg.
9. V. K. Shrivastava (2007), “Patent Law and Indian Pharmaceutical Industry”, The Pharma Review, April.
10. www.dipp.nic.in
11. www.ibef.org
12. www.pharmaceutical.gov.in
13. www.planningcommission.gov.in
14. www.rbi.org.in